Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Andreas Agathangelidis(Aristotle University of Thessaloniki), Arnon P. Kater(Amsterdam University Medical Centers), Csaba Bödör(Semmelweis University), Davide Bagnara(University of Genoa), Kamila Brázdilová(Central European Institute of Technology), Ellen J. van Gastel(Erasmus MC), Eugen Tausch(Universität Ulm), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Christian Brieghel(Copenhagen University Hospital), Raphael Sandaltzopoulos(Democritus University of Thrace), Anne Langlois de Septenville(Sorbonne Université), Lydia Scarfò(IRCCS Ospedale San Raffaele), Lone Bredo Pedersen(Rigshospitalet), Anastasia Chatzidimitriou(Karolinska Institutet), Silvio Veronese(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marine Armand(Sorbonne Université), Panagiotis Baliakas(Uppsala University), Aleksandar Dimovski(Ss. Cyril and Methodius University in Skopje), Manja Meggendorfer(Université Paris-Sud), Teodora Karan-Djurašević(University of Belgrade), Constance Baer(Munich Leukemia Laboratory (Germany)), Andrea Visentin(University of Padua), Monica Facco(University of Padua), Andrey Sudarikov(National Medical Research Center for Hematology), Katrina Vanura(Comprehensive Cancer Center Vienna), Mark Catherwood(University of Ulster), Zadie Davis(Royal Bournemouth Hospital), Larry Mansouri(Uppsala University), Franco Fais(Azienda Ospedaliera di Cosenza), Lisa Bonello(Ospedale Sant'Anna), Cristina Tresoldi(Vita-Salute San Raffaele University), Matthias Ritgen(Goethe University Frankfurt), Karla Plevová(Central European Institute of Technology), Gerlinde Mitterbauer‐Hohendanner(Medical University of Vienna), Valentina Guido(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Renee C. Tschumper, Maria Karypidou(Centre for Research and Technology Hellas), Hana Skuhrová Francová(Masaryk University), Katerina Gemenetzi(Democritus University of Thrace), Bella Biderman(National Medical Research Center for Hematology), Lesley‐Ann Sutton(Karolinska Institutet), Christof Schneider(Universität Ulm), Krzysztof Giannopoulos(Medical University of Lublin), Xiao‐Jie Yan, Sabine Jeromin(Heidelberg University), Alba Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Maria Roumelioti(National and Kapodistrian University of Athens), Véronique Giudicelli(Centre National de la Recherche Scientifique), Sarah Lawless(Belfast Health and Social Care Trust), Theodoros Moysiadis(Centre for Research and Technology Hellas)
Cited by 132
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2018|907